Phase (Ph) I Study of the Safety and Efficacy of the cMET Inhibitor Capmatinib (INC280) in Patients with Advanced cMET plus NSCLC
Todd M. Bauer,Martin Schuler, Rossana Berardi,Wan-Teck Lim,Robin Van Geel,Maja De Jonge,Analia Azaro,Maya Gottfried,Ji-Youn Han,Dae Ho Lee,Mira Wollner,David Hong, Arndt Voge,Angelo Delmonte,Alexander Krohn,Yong Zhang,Matthew Squires,Monica Giovannini,Mikhail Akimov,Dong-Wan Kim JOURNAL OF THORACIC ONCOLOGY（2016）
AI 理解论文
溯源树
样例
